Demand for CBD Products Spurring Large Increase of Farming Operations of Cannabis In U.S.
Cannabis Strategic Ventures, Inc. (OTCQB:NUGS) BREAKING NEWS: Cannabis Strategic Ventures today introduces the strategic direction of its wholly owned and operated flagship farm, NUGS Farm North, located in Northern California. The fully operational, six-acre marijuana cultivation operation is expected to reach complete capacity by the fall of 2019, and will position Cannabis Strategic Ventures as one of the largest cultivators in terms of volume in the state of California.
"We believe the operationalization of NUGS Farm North will enable us to become one of the largest legal cultivators and distributors of multiple types of cannabis products in California and the United States. Located in an area of rich agricultural heritage, the growing conditions at NUGS Farm North will yield a significant tonnage of the highest quality marijuana in the world," said Simon Yu, CEO. Cannabis Strategic Ventures. "We are proud of our teams on the ground and in the corporate office – both of which are diligently working to grow quality plants of some of the most popular varietals, and to secure the financial and operational resources to make this possible."
Cannabis Strategic Ventures provides the following details regarding the operations and revenue guidance for output of cultivation at NUGS Farm North:
"Our team is quickly becoming one of the largest publicly traded operations within the U.S. cannabis marketplace," added Yu. "We thank our investors who continue to support our growth and are excited to provide an update on the details of our extensive financing package." Read this and more news for Cannabis Strategic Ventures at: https://www.financialnewsmedia.com/news-nugs
Other recent developments and major influences in the cannabis industry include: Aphria Inc.
(NYSE: APHA) (TSX: APHA) recently announced that its German subsidiary Aphria Deutschland GmbH ("Aphria Germany") had been awarded a fifth lot for the cultivation of medical cannabis in Germany as part of the Company's previously awarded license from the German Federal Institute for Drugs and Medical Devices ("BfArM"). The additional lot was provisionally awarded to Aphria Germany in April and was secured following a review by a German court, which affirmed the original decision by the BfArM.
With this decision, Aphria Germany won the maximum output from the German tender process – a total of five lots - and stands as the only licensed producer in Germany with the permission to grow all three strains of medical cannabis approved by the BfArM.
HEXO Corp. (NYSE: HEXO) (TSX: HEXO) and Newstrike Brands Ltd. recently announced that they completed the previously announced arrangement (the "Arrangement"), pursuant to which HEXO acquired all of the issued and outstanding common shares of Newstrike (the "Newstrike Shares") by way of a plan of arrangement under the Business Corporations Act (Ontario). following the Arrangement, HEXO has ownership or control over 558,971,064 common shares in the capital of Newstrike representing 100% of the total issued and outstanding share capital of Newstrike.
Aurora Cannabis Inc. (NYSE: ACB) (TSX: ACB) a global leader in the cannabis industry, recently announced that Aurora has exercised its option with EnWave Corporation and that the companies signed an exclusive, royalty-bearing commercial license agreement with sub-licensing rights (the "Agreement") for the use by Aurora of EnWave's proprietary Radiant Energy Vacuum ("REV™") dehydration technology for the drying of cannabis in South America (excluding Peru). Aurora will hold the exclusive master license for the drying of cannabis using REV™ in the South American license territory and will work with EnWave to pursue additional sub-licensing opportunities. Aurora will receive an undisclosed share of royalties derived from any cannabis product dried with REV™ technology by sub-licensees in the South American license territory. This is the third such agreement signed by Aurora and EnWave.
On April 26, 2019, EnWave and Aurora announced that the companies had entered into a royalty-bearing commercial license agreement with sub-licensing rights, providing Aurora with the exclusive rights to EnWave's patented REV™ drying technology for the production of cannabis materials in the European Union, excluding Portugal (the "European License"). Aurora announced its intention to purchase an additional 120kW REV™ machine for its European operations. Additionally, Aurora secured a non-exclusive sub-license to use REV™ technology in Canada, signed an intellectual property agreement with the Company and made a $10 million strategic investment into EnWave.
Terra Tech Corp. (OTCQX: TRTC), a vertically integrated cannabis-focused agriculture company, recently announced that it has launched a legal cannabis delivery service, operating from its state licensed Blüm dispensary in Santa Ana, CA, as of Tuesday, May 14, 2019. Through its Blüm Santa Ana dispensary, Terra Tech is now a major supplier of medical and adult-use cannabis to Santa Ana and the surrounding cities, such as Irvine, Laguna Beach and Newport Beach. All of the aforementioned cities suffer from a scarcity of existing cannabis dispensaries. Launching a premier delivery service enables the Company to expand distribution of its best-in-class cannabis products to reach an even greater number of patients and customers. The delivery service is fully licensed and compliant with all state regulations.
DISCLAIMER: FN Media Group LLC (FNM), which owns and operates Financialnewsmedia.com and MarketNewsUpdates.com, is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNM is NOT affiliated in any manner with any company mentioned herein. FNM and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNM's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release. FNM is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. For current services performed FNM has been compensated forty five hundred dollars for news coverage of the current press releases issued by Cannabis Strategic Ventures, Inc by the company. FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNM undertakes no obligation to update such statements.
Contact Information:
[email protected]
+1(561)325-8757
